Report cover image

Hospital Acquired Infection (HAI) Control Markets

Published Feb 22, 2017
Length 242 Pages
SKU # KLI15261546

Description

Hospital Acquired Infection (HAI) Control Markets

Hospital Acquired Infection (HAI) Control Markets provides a revenue analysis for the prevention, testing, and treatment of infections in the healthcare surroundings, including the world revenues for 2010-2021 for hospital infection control, for hospital infection treatment, and for hospital infection prevention equipment and consumables (sterilization/disinfection). Sales information is also provided for the different market segments by primary geographic region (United States, Europe, rest of world) and leading manufacturers’ shares. Merck, Pfizer, GlaxoSmithKline, and Bayer are among the key companies in HAI control markets are among those manufacturers featured in the report’s competitor analysis.

Table of Contents

242 Pages
    • Overview
    • The Nosocomial Infection
    • Market Scope
    • Research Methodology
    • Industry Challenges
    • Total Size and Growth of the Market
    • Issues and Trends Affecting Market
    • Overview
    • Common Hospital (Nosocomial) Infections
    • Description of Infections
    • World Demographics
    • U.S. Government's National Plan to Prevent Healthcare Associated Infections (HAIs)
    • Steering Committee
    • Epidemiology and Laboratory Capacity for Infectious Diseases
    • Affordable Care Act (ACA) Funding
    • Emerging Infections Program
    • The Department of Health and Human Services: 2017 Budget Highlights
    • National Healthcare Safety Network
    • Healthcare Infection Surveillance Process
    • Pharmaceutical Manufacturer and Marketer Trends
    • Overview
    • Market Overview
    • High-Risk Facilities or Departments
    • Equipment and Solutions
    • Heat/Steam Sterilization
    • Chemical and Gas Sterilization
    • Radiation Sterilization
    • Competitive Analysis
    • Overview
    • Total Market Size and Forecast
    • Testing for Nosocomial Infections
    • Specific Serious Healthcare Infection Testing
    • Developments
    • Competitive Analysis
    • Overview
    • Total Market Size and Forecast
    • Principles of Anti-bacterial Therapy
    • Classifications of Antibacterial Products
    • Market Size and Sales Distribution by Antibiotic Class
    • Infections and Drug Resistance
    • Qualified Infectious Disease Program Designations
    • New Developments
    • Competitive Analysis
    • Market Considerations
    • Market Overview
    • Introduction
    • 3M
    • Abbott Laboratories
    • AbbVie
    • Advanced Sterilization Products
    • Alere
    • AstraZeneca
    • Bayer
    • Becton, Dickinson and Company
    • Belimed
    • bioMérieux S.A.
    • Cantel Medical Corp.
    • Danaher Corporation
    • Ecolab, Inc.
    • Getinge Group
    • GlaxoSmithKline plc
    • Merck & Co.
    • Pfizer, Inc.
    • Roche
    • Sakura Seiki Co., Ltd.
    • Steris plc
    • TSO3, Inc.
    • List of Participants
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.